SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-301827
Filing Date
2019-11-27
Accepted
2019-11-27 08:40:05
Documents
5
Period of Report
2019-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d834742d8k.htm 8-K 21945
2 EX-1.1 d834742dex11.htm EX-1.1 169079
3 EX-5.1 d834742dex51.htm EX-5.1 13541
4 GRAPHIC g834742g1119091804526.jpg GRAPHIC 1843
5 GRAPHIC g834742sp4.jpg GRAPHIC 3891
  Complete submission text file 0001193125-19-301827.txt   213948
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 191253258
SIC: 2834 Pharmaceutical Preparations